+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Human Microbiome Market Research Report by Disease (Acute Diarrhea, Autoimmune Disorders, and Cancer), Technology, Product, Therapeutic Area, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 224 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4857894
UP TO OFF until Dec 31st 2022
The Global Human Microbiome Market size was estimated at USD 1,053.28 million in 2021, USD 1,291.04 million in 2022, and is projected to grow at a CAGR 23.43% to reach USD 3,724.81 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Human Microbiome to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease, the market was studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity.
  • Based on Technology, the market was studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology.
  • Based on Product, the market was studied across Diagnostic Devices, Drugs, Foods, and Prebiotic & Probiotics.
  • Based on Therapeutic Area, the market was studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health.
  • Based on Application, the market was studied across Diagnostics and Therapeutics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Human Microbiome market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Microbiome Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market, including 4D pharma PLC, AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Intralytix, Inc., Locus Biosciences, Inc., Merck and Co. Inc., Metabiomics Corporation, Osel Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Synthetic Biologics, Inc., Vedanta Biosciences, Inc., and Yakult Honsha Co., Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Human Microbiome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Microbiome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Microbiome Market?
4. What is the competitive strategic window for opportunities in the Global Human Microbiome Market?
5. What are the technology trends and regulatory frameworks in the Global Human Microbiome Market?
6. What is the market share of the leading vendors in the Global Human Microbiome Market?
7. What modes and strategic moves are considered suitable for entering the Global Human Microbiome Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
5.1.2. Restraints
5.1.2.1. Limited Expertise and Safety Issue Related to Microbiome Therapeutics
5.1.3. Opportunities
5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
5.1.4. Challenges
5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
5.2. Cumulative Impact of COVID-19
6. Human Microbiome Market, by Disease
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity
7. Human Microbiome Market, by Technology
7.1. Introduction
7.2. 16S Rrna Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. Human Microbiome Market, by Product
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics
9. Human Microbiome Market, by Therapeutic Area
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women's Health
10. Human Microbiome Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. Americas Human Microbiome Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Human Microbiome Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
13. Europe, Middle East & Africa Human Microbiome Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. Competitive Landscape
14.1. Fpnv Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, by Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. 4D Pharma plc
15.2. Aobiome, LLC
15.3. Astarte Medical Partners, Inc
15.4. Axial Therapeutics, Inc.
15.5. Dupont De Nemours, Inc.
15.6. Enterome Bioscience
15.7. Evelo Biosciences, Inc.
15.8. Exeliom Biosciences Sas
15.9. Ferring B.V.
15.10. Finch Therapeutics Group, Inc.
15.11. Intralytix, Inc.
15.12. Locus Biosciences, Inc.
15.13. Merck and Co. Inc.
15.14. Metabiomics Corporation
15.15. Osel Inc.
15.16. Second Genome, Inc.
15.17. Seres Therapeutics, Inc.
15.18. Synlogic, Inc.
15.19. Synthetic Biologics, Inc.
15.20. Vedanta Biosciences, Inc.
15.21. Yakult Honsha Co., Ltd.
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET DYNAMICS
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2027
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2027
FIGURE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
FIGURE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2027
FIGURE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2019-2027 (USD MILLION)
FIGURE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 61. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2027
FIGURE 63. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2019-2027 (USD MILLION)
FIGURE 64. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 65. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2019-2027 (USD MILLION)
FIGURE 66. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 70. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2027
FIGURE 71. ARGENTINA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. BRAZIL HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. CANADA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. MEXICO HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 77. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2027
FIGURE 79. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 81. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 82. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2027
FIGURE 83. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. CHINA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. INDIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. INDONESIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. JAPAN HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. MALAYSIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. SINGAPORE HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. TAIWAN HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. THAILAND HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 95. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 96. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 97. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2027
FIGURE 98. FRANCE HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. GERMANY HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. ITALY HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. QATAR HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. RUSSIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. SPAIN HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 109. GLOBAL HUMAN MICROBIOME MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 110. GLOBAL HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 111. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HUMAN MICROBIOME MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 68. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 89. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 90. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 94. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 95. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 100. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2019-2027 (USD MILLION)
TABLE 105. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY STATE, 2019-2027 (USD MILLION)
TABLE 107. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 110. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 111. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 113. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 115. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 116. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 118. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 120. AMERICAS HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 123. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 124. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 125. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 126. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 127. ARGENTINA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 129. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 130. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 131. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 132. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 133. BRAZIL HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 135. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 136. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 137. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 138. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 139. CANADA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 140. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 141. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 142. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 143. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 144. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 145. MEXICO HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 147. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 148. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 149. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 150. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 151. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 153. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 154. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 155. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 156. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 157. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 158. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 160. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 161. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 162. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 163. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 164. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 165. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 167. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 168. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 169. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 170. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 171. CHINA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 172. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 173. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 174. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 175. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 176. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. INDIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 179. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 180. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 181. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 182. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 183. INDONESIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 184. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 185. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 186. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 187. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 188. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 189. JAPAN HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 190. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 191. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 192. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 193. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 194. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 195. MALAYSIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 196. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 197. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 198. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 199. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 200. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 201. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 202. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 203. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 204. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 205. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 206. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 207. SINGAPORE HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 208. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 209. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 210. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 211. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 212. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 213. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 214. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 215. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 216. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 217. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 218. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 219. TAIWAN HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 220. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 221. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 222. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 223. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 224. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 225. THAILAND HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 226. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 227. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 228. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 229. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 230. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 238. FRANCE HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 239. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 240. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 241. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 242. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 243. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 244. GERMANY HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 245. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 246. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 247. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 248. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 249. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 250. ITALY HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 251. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 252. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 253. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 254. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 255. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 256. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 257. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 258. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 259. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 260. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 261. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 262. QATAR HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 263. QATAR HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 264. QATAR HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 265. QATAR HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 266. QATAR HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 267. QATAR HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 268. RUSSIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 269. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 270. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 271. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 272. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 273. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 274. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 275. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 276. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 277. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 278. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 279. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 280. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 281. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 282. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 283. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 284. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 285. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 286. SPAIN HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 287. SPAIN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 288. SPAIN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 289. SPAIN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 290. SPAIN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 291. SPAIN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 298. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 299. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019-2027 (USD MILLION)
TABLE 300. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 301. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 302. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD MILLION)
TABLE 303. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 304. GLOBAL HUMAN MICROBIOME MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 305. GLOBAL HUMAN MICROBIOME MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 306. GLOBAL HUMAN MICROBIOME MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 307. GLOBAL HUMAN MICROBIOME MARKET RANKING
TABLE 308. GLOBAL HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2021
TABLE 309. GLOBAL HUMAN MICROBIOME MARKET MERGER & ACQUISITION
TABLE 310. GLOBAL HUMAN MICROBIOME MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 311. GLOBAL HUMAN MICROBIOME MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 312. GLOBAL HUMAN MICROBIOME MARKET INVESTMENT & FUNDING
TABLE 313. GLOBAL HUMAN MICROBIOME MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 314. GLOBAL HUMAN MICROBIOME MARKET: LICENSE & PRICING

Companies Mentioned

  • 4D pharma PLC
  • AOBiome, LLC
  • Astarte Medical Partners, Inc
  • Axial Therapeutics, Inc.
  • DuPont de Nemours, Inc.
  • Enterome Bioscience
  • Evelo Biosciences, Inc.
  • Exeliom Biosciences SAS
  • Ferring B.V.
  • Finch Therapeutics Group, Inc.
  • Intralytix, Inc.
  • Locus Biosciences, Inc.
  • Merck and Co. Inc.
  • Metabiomics Corporation
  • Osel Inc.
  • Second Genome, Inc.
  • Seres Therapeutics, Inc.
  • Synlogic, Inc.
  • Synthetic Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Yakult Honsha Co., Ltd.

Methodology

Loading
LOADING...